La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Evaxion Biotech Salute del bilancio
Salute finanziaria criteri di controllo 3/6
Evaxion Biotech has a total shareholder equity of $1.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.2M and $21.1M respectively.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
US$0
Debito
Indice di copertura degli interessi | n/a |
Contanti | US$11.73m |
Patrimonio netto | US$1.25m |
Totale passività | US$21.06m |
Totale attività | US$15.23m |
Aggiornamenti recenti sulla salute finanziaria
Is Evaxion Biotech (NASDAQ:EVAX) In A Good Position To Invest In Growth?
Oct 27We're Hopeful That Evaxion Biotech (NASDAQ:EVAX) Will Use Its Cash Wisely
Jun 29Recent updates
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
Mar 31Evaxion Biotech names Per Norlén as CEO
Oct 05Evaxion stock rises 11% as enrollment begins in trial of immunotherapy EVX-01 for skin cancer
Sep 21Evaxion Biotech ADS GAAP EPS of -$0.20 beats by $0.10
Aug 10Evaxion Biotech announces new CEO as Lars Wegner resigns
Aug 02Is Evaxion Biotech (NASDAQ:EVAX) In A Good Position To Invest In Growth?
Oct 27We're Hopeful That Evaxion Biotech (NASDAQ:EVAX) Will Use Its Cash Wisely
Jun 29Evaxion Biotech posts preclinical proof of concept data for AI-powered vaccine platform
Jun 03Analisi della posizione finanziaria
Passività a breve termine: EVAX's short term assets ($11.7M) exceed its short term liabilities ($7.1M).
Passività a lungo termine: EVAX's short term assets ($11.7M) do not cover its long term liabilities ($14.0M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: EVAX is debt free.
Riduzione del debito: EVAX has no debt compared to 5 years ago when its debt to equity ratio was 97.8%.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: EVAX has less than a year of cash runway based on its current free cash flow.
Previsione Cash Runway: EVAX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.3% each year